Nuvectis Pharma Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NVCT is expected to report earnings to fall 22.00% to -23 cents per share on November 10
Q3'26
Est.
$-0.23
Q2'26
Beat
by $0.02
Q1'26
Beat
by $0.05
Q4'25
Missed
by $0.06
Q3'25
Missed
by $0.19
The last earnings report on August 04 showed earnings per share of -30 cents, beating the estimate of -32 cents. With 49.05K shares outstanding, the current market capitalization sits at 679.32M.